RxDoctor Payments DataLook up a doctor →

Rita Nanda

Hematology & Oncology · Chicago, ILNPI 1568524015

Payments from drug & device makers

$3,480,121in general payments, 2019–2025

Across 498 payments — averaging $6988.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$1.7M
  • Seagen Inc.$497K
  • Genentech, Inc.$388K
  • Gilead$235K
  • AstraZeneca$225K
  • Pfizer$148K
  • plus $281K from 16 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck148$1,705,968
Seagen Inc.30$497,451
Genentech, Inc.38$387,666
Gilead76$234,780
AstraZeneca34$225,096
Pfizer(2 entities)49$148,059
Genentech USA, Inc.45$47,821
Jazz Pharmaceuticals Inc.6$37,866
Astrazeneca UK Limited6$37,035
Immunomedics, Inc.7$34,375
Regeneron10$32,672
Taiho Oncology, Inc.6$20,140
Daiichi Sankyo Inc.15$19,062
Bristol Myers Squibb1$13,200
AbbVie5$11,350
Sanofi3$8,563
GE HealthCare6$6,407
Corcept Therapeutics3$4,655
Eli Lilly3$2,830
Modernatx, Inc.1$2,746
Clovis Oncology, Inc.2$1,613
Stemline Therapeutics Inc.4$767

How this compares

$3,480,121 in reported general payments places this provider in the 95th percentile of 580 hematology & oncology providers in Illinois.

See all hematology & oncology providers in Illinois

Medicare billing

Part B allowed, 2024
$25,272
Medicare patients
94
Services billed
234

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →